You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
心泰醫療(02291.HK)盈喜:預計2024年度純利2.3億至2.6億元
格隆匯 03-21 18:02

格隆匯3月21日丨心泰醫療(02291.HK)發佈公吿,截至2024年12月31日止年度(“報吿期”),集團預期將錄得公司擁有人應占純利介乎約人民幣2.30億元至約人民幣2.60億元,而截至2023年12月31日止年度則錄得公司擁有人應占利潤人民幣1.515億元。

公吿表示,股東應占純利的預期增加主要是由於集團的生物可降封堵器產品系列於報吿期內的銷量較截至2023年12月31日止年度大幅增加。此增長受集團前瞻性研發策略思維、專業性學術推廣、強大的商業化能力所推動。公司相信,隨着更多創新產品陸續商業化,集團會繼續保持強勁的業務表現,努力在未來的年度為股東帶來更好的回報。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account